[18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis

ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI

(2016) E. R. Gerstner et al.   CLINICAL CANCER RESEARCH

Change in 18F-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment

(2016) Shigeru Yamaguchi et al.   PLoS One

Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: From biology to clinical use

(2015) Jaromir Pastorek et al.   SEMINARS IN CANCER BIOLOGY

Hypoxia Imaging in Gliomas With 18F-Fluoromisonidazole PET: Toward Clinical Translation

(2015) Christopher Bell et al.   SEMINARS IN NUCLEAR MEDICINE

[ 18 F]-fluoro- l -thymidine PET and advanced MRI for preoperative grading of gliomas

(2015) S. Collet et al.   NeuroImage-Clinical

Correlation between 18F-fluoromisonidazole PET and expression of HIF-1α and VEGF in newly diagnosed and recurrent malignant gliomas

(2014) Nobuyuki Kawai et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

GBM's multifaceted landscape: highlighting regional and microenvironmental heterogeneity

(2014) A. Vartanian et al.   NEURO-ONCOLOGY

The Relationship among Hypoxia, Proliferation, and Outcome in Patients with De Novo Glioblastoma: A Pilot Study

(2014) Sydney M. Evans et al.   Translational Oncology

Angiopoietins in angiogenesis

(2012) Ernesta Fagiani et al.   CANCER LETTERS

18F-Fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas

(2012) Kenji Hirata et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Hypoxia assessed by 18F-fluoromisonidazole positron emission tomography in newly diagnosed gliomas

(2012) Yuka Yamamoto et al.   NUCLEAR MEDICINE COMMUNICATIONS

Low-Field Magnetic Resonance Imaging to Visualize Chronic and Cycling Hypoxia in Tumor-Bearing Mice

(2010) H. Yasui et al.   CANCER RESEARCH

Quantitative Metrics of Net Proliferation and Invasion Link Biological Aggressiveness Assessed by MRI with Hypoxia Assessed by FMISO-PET in Newly Diagnosed Glioblastomas

(2009) M. D. Szeto et al.   CANCER RESEARCH

Hypoxia-regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme

(2008) Jeannette R. Flynn et al.   CANCER

Regional Hypoxia in Glioblastoma Multiforme Quantified with [18F]Fluoromisonidazole Positron Emission Tomography before Radiotherapy: Correlation with Time to Progression and Survival

(2008) A. M. Spence et al.   CLINICAL CANCER RESEARCH

Complementary but Distinct Roles for MRI and 18F-Fluoromisonidazole PET in the Assessment of Human Glioblastomas

(2008) K. R. Swanson et al.   JOURNAL OF NUCLEAR MEDICINE

Advances in Evaluation of Primary Brain Tumors

(2008) Wei Chen et al.   SEMINARS IN NUCLEAR MEDICINE